Abstract: A semiconductor device includes first to sixth active patterns extending in a first direction and spaced apart in the first direction and a second direction; a field insulating layer between the first and second active patterns, an upper surface thereof being lower than upper surfaces of the first and second active patterns; a first gate structure on the field insulating layer and the first active pattern and extending in the second direction; a second gate structure on the field insulating layer and the second active pattern and extending in the second direction; a first separation trench extending between the second and third active patterns and the fifth and sixth active patterns, and a second separation trench extending between the first and second gate structures, wherein a lowest surface of the first separation trench is higher than a lowest surface of the second separation trench.

Abstract: Provided are a method of screening for novel therapeutic targets to develop therapeutic agents for colon cancer, and prognostic biomarkers for colon cancer treatment which are screened using the same.

Abstract: A semiconductor device includes a substrate including NMOS and PMOS regions; first and second active patterns on the NMOS region; third and fourth active patterns on the PMOS region, the third active pattern being spaced apart from the first active pattern; a first dummy gate structure on the first and third active patterns; a second dummy gate structure on the second and fourth active patterns; a normal gate structure on the third active pattern; a first source/drain pattern on the third active pattern and between the normal gate structure and the first dummy gate structure; and a first element separation structure between the first and second dummy gate structures and separating the third and fourth active patterns, wherein the first dummy gate structure includes a first dummy insulation gate intersecting the third active pattern.

Abstract: Provided are a composition for inhibiting immune cell proliferation, including sialyllactose or a derivative thereof as an active ingredient, and a method of inhibiting immune cell proliferation, wherein the composition and the method may decrease expression of chemokines, decrease expression of pro-inflammatory cytokines, decrease production of inflammatory mediators, decrease expression of COX2, and decrease production of PEG2, and therefore, may be useful for the prevention or treatment of atopic dermatitis or arthritis.

Abstract: The present invention relates to heat-killed Lactobacillus rhamnosus conjugated to a polysaccharide polymer binder, a preparation method therefor and a use thereof. The heat-killed Lactobacillus rhamnosus conjugated to a polysaccharide polymer binder of the present invention has an excellent therapeutic effect for atopic diseases, and particularly has high industrial applicability because membrane adhesion competitiveness, which is an advantage of existing lactic acid bacteria, is significantly improved, thereby exhibiting dermatitis preventing, alleviating and treating effects of the same level as steroid-based drugs.

Abstract: A semiconductor device includes a substrate including NMOS and PMOS regions; first and second active patterns on the NMOS region; third and fourth active patterns on the PMOS region, the third active pattern being spaced apart from the first active pattern; a first dummy gate structure on the first and third active patterns; a second dummy gate structure on the second and fourth active patterns; a normal gate structure on the third active pattern; a first source/drain pattern on the third active pattern and between the normal gate structure and the first dummy gate structure; and a first element separation structure between the first and second dummy gate structures and separating the third and fourth active patterns, wherein the first dummy gate structure includes a first dummy insulation gate intersecting the third active pattern.

Abstract: Disclosed is a polypeptide having a phase transition behavior, wherein the polypeptide consists of a Val-Pro-Gly-Xaa-Gly pentapeptide repeat or a Val-Pro-Ala-Xaa-Gly) pentapeptide repeat, and the polypeptide includes a [Val-Pro-Gly-Xaa-Gly]n or a [Val-Pro-Ala-Xaa-Gly]n (SEQ ID NO:2) pentapeptide repeat. In addition, the present invention provides a multi-stimuli polypeptide composed of polypeptide-calmodulin-polypeptide having a phase transition behavior and a hydrogel prepared using the same. A dynamic protein hydrogel according to the present invention may be used as a drug carrier, as a scaffold for tissue engineering or as a kit for tissue or organ regeneration.

Abstract: A semiconductor device is provided.

Abstract: A semiconductor device includes a substrate including NMOS and PMOS regions; first and second active patterns on the NMOS region; third and fourth active patterns on the PMOS region, the third active pattern being spaced apart from the first active pattern; a first dummy gate structure on the first and third active patterns; a second dummy gate structure on the second and fourth active patterns; a normal gate structure on the third active pattern; a first source/drain pattern on the third active pattern and between the normal gate structure and the first dummy gate structure; and a first element separation structure between the first and second dummy gate structures and separating the third and fourth active patterns, wherein the first dummy gate structure includes a first dummy insulation gate intersecting the third active pattern.

Abstract: A semiconductor device includes first to sixth active patterns extending in a first direction and spaced apart in the first direction and a second direction; a field insulating layer between the first and second active patterns, an upper surface thereof being lower than upper surfaces of the first and second active patterns; a first gate structure on the field insulating layer and the first active pattern and extending in the second direction; a second gate structure on the field insulating layer and the second active pattern and extending in the second direction; a first separation trench extending between the second and third active patterns and the fifth and sixth active patterns, and a second separation trench extending between the first and second gate structures, wherein a lowest surface of the first separation trench is higher than a lowest surface of the second separation trench.

Abstract: The present disclosure relates to a hydrocracking catalyst for preparing a C6-C9 light aromatic hydrocarbons having an increased BTX content from a polycyclic aromatic hydrocarbon, a method for preparing the same and a method for preparing a C6-C9 light aromatic hydrocarbons having an increased BTX content by using the same. More specifically, an effect of obtaining a C6-C9 light aromatic hydrocarbons having an increased BTX content with a high yield from the byproducts of oil refining and petrochemical processes, which contain polycyclic aromatic hydrocarbons such as naphthalene, alkylnaphthalene, etc., can be achieved by using a catalyst in which one or more metal selected from group VIII and one or more metal selected from group VIB are supported on a composite zeolite support of zeolite beta and zeolite ZSM-5.

Abstract: Provided are a composition for inhibiting immune cell proliferation, including sialyllactose or a derivative thereof as an active ingredient, and a method of inhibiting immune cell proliferation, wherein the composition and the method may decrease expression of chemokines, decrease expression of pro-inflammatory cytokines, decrease production of inflammatory mediators, decrease expression of COX2, and decrease production of PEG2, and therefore, may be useful for the prevention or treatment of atopic dermatitis or arthritis.

Abstract: Disclosed is a polypeptide having a phase transition behavior, wherein the polypeptide consists of a Val-Pro-Gly-Xaa-Gly (SEQ ID NO: 1) pentapeptide repeat or a Val-Pro-Ala-Xaa-Gly (SEQ ID NO: 2) pentapeptide repeat, and the polypeptide includes a [Val-Pro-Gly-Xaa-Gly (SEQ ID NO: 1)]n or a [Val-Pro-Ala-Xaa-Gly (SEQ ID NO: 1)]n pentapeptide repeat. In addition, the present invention provides a multi-stimuli polypeptide composed of polypeptide-calmodulin-polypeptide having a phase transition behavior and a hydrogel prepared using the same. A dynamic protein hydrogel according to the present invention may be used as a drug carrier, as a scaffold for tissue engineering or as a kit for tissue or organ regeneration.

Abstract: An object of the present invention is to provide a method for releasing oocyte maturation regulation by suppressing expression of a gene capable of regulating oocyte maturation in shrimps by the RNA interference method. The present invention provides a method for blocking oocyte maturation inhibition in farmed shrimps to be used as spawners (hereafter, “farmed shrimp”), comprising suppressing the expression of a vitellogenesis-inhibiting hormone (VIH) gene in shrimps by RNA interference using double-stranded RNA (dsRNA) targeting mRNA of the vitellogenesis-inhibiting hormone gene in farmed shrimps.

Abstract: A power transmission structure for a hybrid vehicle having two motor generators and three clutches includes: an engine (10), a second motor (20), and an output shaft (40) transmitting power from the engine (10) and the second motor (20) to a transmission (30), wherein the second motor (20) is disposed in parallel with the engine (10), a first motor (50) directly connected to the output shaft (40) of the transmission (30) is disposed between the second motor (20) and the transmission (30), the output shaft (40) is connected to the transmission (30) through a center of a motor (30), a first clutch (111) and a second clutch (112) constituting a double clutch are disposed on the output shaft (40) between the engine (10) and the second motor (20), and a third clutch (113) is disposed between the second motor (20) and the first motor (50).

Abstract: Disclosed are a successive optical analysis system for optically analyzing a flow cell, including: at least one stage on which the flow cell is loaded; at least two optical analyzing units configured to optically analyze the flow cell loaded on the stage; and a conveying unit configured to convey at least one of the stage and the optical analyzing unit and align positions of the stage and the optical analyzing unit, and a successive optical analysis method using the same.

Abstract: The present invention relates to a finishing panel fixing device, and more particularly, to a finishing panel fixing device that fixes a finishing panel so that the finishing panel can be stably fixed when installing the finishing panel for finishing an indoor or outdoor wall surface or a floor. The finishing panel fixing device according to the present invention is extremely simple to assemble and install, and thus can reduce the time required for assembly, installation, and disassembly. The finishing panel fixing device also enhances fixability with respect to the finishing panel so that movement of the finishing panel due to an external force is prevented, and thus can also be applied to the finishing of an outdoor wall. The finishing panel fixing device can also facilitate maintenance.

Abstract: Disclosed are an optical analysis device and an optical analysis method. The present invention provides an optical analysis device for optically analyzing a flow cell, including: a light source configured to emit light to the flow cell; an optical detector including a plurality of detection elements that detects optical signals from reaction regions of the flow cell; and an optical mask including light transmissive mask holes disposed at a front end of each of the detection elements, and an optical analysis method using the same.

Abstract: The present disclosure relates to a copolyester including a polymer formed by polymerization of monomers represented by the following Structural Formula 1 to Structural Formula 4: (in the above Structural Formula 1 to Structural Formula 4, R1 to R18 are identical to or different from each other and are each independently selected from the group consisting of H, substituted or unsubstituted linear or branched C1-C20 alkyl and substituted or unsubstituted C6-C20 aryl).